Abraham Bout

This inventor holds 55 USPTO granted patents and 5 published patent applications, plus 15 CIPO patents and 12 EPO patents, primarily in Recombinant Protein Production (CPC class C07K). Top assignees: Crucell Holland B.v., Introgene B.v., Merus B.v.. Active years: 1999-2021.

USPTO Granted Patents = 55 (Patent Applications = 5)

% Patents Active = 69.1

CIPO Patents = 15 (Patent Applications = 5)

EPO Patents = 12 (Patent Applications = 6)

Average Co-Inventor Count = 3.2

ph-index = 16

Forward Citations = 1,190(Granted Patents)

Forward Citations (Not Self Cited) = 1,031(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Moenkepelle, NL (2001)
Ar Moerkapelle, NL (1999 - 2012)
Moerkapelle, NL (1999 - 2020)
Leiden, NL (2016 - 2021)

Company Filing History:

Galapagos Genomics N.v.

patents

5. 2 out of 11

Mallinckrodt Pharma IP Trading D.a.c.

Galapagos Geonomics N.v.

patent

8. 1 out of 1

Mallinckrodt Oharma IP Trading D.a.c.

Universiteit Utrecht Introgene B.v.

patent

11. 2 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2021

Loading Chart...

Areas of Expertise:

Recombinant Antibodies

Adenovirus Vectors

Gene Delivery

Fibrinogen Preparations

Protein Production

Nucleic Acid Delivery

Functional Genomics

Cell Transduction

Tissue Tropism

Post-Translational Modifications

Chimeric Adenoviruses

Mesenchymal Stem Cells

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10934571 - Recombinant production of mixtures of antibodies (2021-03-02),

2. 10562956 - Recombinant fibrinogen (2020-02-18),

3. RE47770 - Recombinant production of mixtures of antibodies (2019-12-16),

4. 10004787 - Fibrinogen preparations enriched in fibrinogen with an extended alpha chain (2018-06-26),

5. 9694054 - Fibrinogen preparations enriched in fibrinogen with an extended alpha chain (2017-07-04),

6. 9303081 - Recombinant production of mixtures of antibodies (2016-04-05),

7. 8236561 - Efficient production of IgA in recombinant mammalian cells (2012-08-07),

8. 8236293 - Means and methods for nucleic acid delivery vehicle design and nucleic acid transfer (2012-08-07),

9. 8221971 - Serotype of adenovirus and uses thereof (2012-07-17),

10. 7968087 - Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells (2011-06-28),

11. 7932360 - Recombinant production of mixtures of antibodies (2011-04-26),

12. 7927834 - Recombinant production of mixtures of antibodies (2011-04-19),

13. 7906113 - Serotype of adenovirus and uses thereof (2011-03-15),

14. 7820440 - Means and methods for producing adenovirus vectors (2010-10-26),

15. 7785833 - Methods and means for producing proteins with predetermined post-translational modifications (2010-08-31),

Title: Inventor Abraham Bout: Revolutionizing Industries with Innovation

Introduction: Abraham Bout, a visionary inventor hailing from Moerkapelle, NL, has been at the forefront of groundbreaking innovations that have reshaped various industries.

Latest Patents: Abraham Bout's latest patents include cutting-edge technologies in renewable energy, sustainable agriculture, and advanced healthcare solutions, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Abraham Bout has consistently delivered pioneering inventions that have garnered international acclaim. His ability to blend creativity with practicality has led to the development of solutions that address pressing global challenges.

Collaborations: Throughout his career, Abraham Bout has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life. His collaborative spirit and passion for innovation have resulted in successful partnerships that have accelerated the implementation of his groundbreaking ideas.

Conclusion: In conclusion, Abraham Bout stands as a beacon of innovation, continuously pushing the boundaries of what is possible through his inventive spirit and dedication to creating a better world through technology.